ВІКТОЗА

ਉਤਪਾਦ ਝਲਕ

About VIKTOZA

VIKTOZA® (Viktosa) – IN'IeKTsIINYI medicine, that contains LIRAHLUTYD – SYNTETYChNYI ANALOH LIuDSKOHO HLIuKAHONOPODIBNOHO PEPTYDU‑1 (HPP‑1). Medicine is used for treatment NEDOSTATNO KONTROLOVANOHO TsUKROVOHO DIABETU II type in adults, PIDLITKIV and children from 10 years. It is used as DOPOVNENNIa to DIIeTY and FIZYChNYKh NAVANTAZhEN, in MONOTERAPII or V combination with other agents for treatment DIABETU.

Composition

Active substance: LIRAHLUTYD. 1 ml solution contains 6 mg LIRAHLUTYDU, A one POPEREDNO ZAPOVNENA ShPRYTs‑RUChKA – 18 mg in 3 ml. Excipients: sodium HIDROFOSFAT DYHIDRAT, PROPILENHLIKOL, FENOL, sodium hydroxide, acid KhLORYSTOVODNA, water for injections.

Indications

Medicine is intended for the treatment of NEDOSTATNO KONTROLOVANOHO TsUKROVOHO DIABETU II type in adults, PIDLITKIV and children from 10 years. Its are used as in cases, when metformin NEDOTsILNYI within NEPERENOSYMIST or PROTYPOKAZANNIa, TAK and V combination with other ANTYDIABETYChNYMY agents. DODATKOVA information about DOSLIDZhENNIa EFEKTYVNOSTI and VPLYVU on SERTsEVO‑SUDYNNI PODII NAVEDENA V ROZDILAKh «OSOBLYVOSTI use», «VZAIeMODIIa with other LIKARSKYMY agents» and «FARMAKODYNAMIKA».

Pharmacological properties

LIRAHLUTYD Ie ANALOHOM HPP‑1 with 97 % HOMOLOHIIeIu to LIuDSKOHO HORMONU INKRETYNU, that activates HPP‑1‑RETsEPTORY PIDShLUNKOVYKh β‑cells and PIDSYLIuIe HLIuKOZOZALEZhNU SEKRETsIIu insulin. PROLONHOVANA DIIa is provided SAMOASOTsIATsIIeIu, bindingM with ALBUMINOM and PIDVYShchENOIu STIIKISTIu to FERMENTIV DPP‑4 and NEP, that allows VVODYTY medicine ODYN once on DOBU. Pharmacokinetics and FARMAKODYNAMIKA LIRAHLUTYDU in LIuDEI PIDTRYMUIuT its TRYVALU action after PIDShKIRNOHO administration.

Source: Compendium